Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors associated with dizygotic twinning after IVF treatment with double embryo transfer.
Groeneveld E, Lambers MJ, Stakelbeek ME, Mooij TM, van den Belt-Dusebout AW, Heymans MW, Schats R, Hompes PG, Hoek A, Burger CW, van Leeuwen FE, Lambalk CB; OMEGA-project group. Groeneveld E, et al. Among authors: van leeuwen fe, van den belt dusebout aw. Hum Reprod. 2012 Oct;27(10):2966-70. doi: 10.1093/humrep/des258. Epub 2012 Jul 10. Hum Reprod. 2012. PMID: 22786776
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R. van Leeuwen FE, et al. Among authors: van den belt dusebout aw. J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7. doi: 10.1093/jnci/87.20.1530. J Natl Cancer Inst. 1995. PMID: 7563187
Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R. van Leeuwen FE, et al. Among authors: van heerde p, van den belt dusebout aw, van kerkhoff eh. J Clin Oncol. 1994 Feb;12(2):312-25. doi: 10.1200/JCO.1994.12.2.312. J Clin Oncol. 1994. PMID: 8113838
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH, Pinedo HM, Somers R. van Leeuwen FE, et al. Among authors: van den belt dusebout aw, van kerkhoff eh. J Clin Oncol. 1994 May;12(5):1063-73. doi: 10.1200/JCO.1994.12.5.1063. J Clin Oncol. 1994. PMID: 8164031
521 results